Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 983-987

  Ding, Yu Mei ^a   Dong, Ji Hua ^a   Chen, Li Li ^a   Zhang, Han Dong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Galectin 1; Oral leukoplakia; Oral squamous cell carcinoma

Indexed keywords

GALECTIN 1; MESSENGER RNA;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING; AGED; CHEMISTRY; GENETICS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FEMALE; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RNA, MESSENGER;

EID: 67449102212     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000312     Document Type: Article

References (26)

1. Lippman SM and Hong WK: Molecular markers of the risk of oral cancer. N Engl J Med 344: 1323-1326, 2001.
2. Mao L, Hong WK and Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 5: 311-316, 2004.
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics. CA Cancer J Clin 55: 74-108, 2005.
4. Broche LM, Navneet Bhadal, Lewis MP, et al: Early detection of oral cancer: is dielectrophoresis the answer? Oral Oncol 43: 199-203, 2006.
5. Papadimitrakopoulou VA, Hong WK, Lee JS, et al: Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst 89: 257-258, 1997.
6. Brewer CF: Binding and cross-linking properties of galectins. Biochim Biophys Acta 1572: 255-262, 2002.
7. Danguy A, Camby I and Kiss R: Galectins and cancer. Biochim Biophys Acta 1572: 285-293, 2002.
8. Tinari N, Kuwabara I, Huflejt ME, et al: Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 91: 167-172, 2001.
9. Saussez S, Decaestecker C, Lorfevre F, et al: Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52: 483-493, 2008.
10. Barondes SH, Castronovo V, Cooper DN, et al: Galectins: a family of animal ß-galactoside-binding lectins. Cell 76: 597-598, 1994.
11. Cooper DN: Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572: 209-231, 2002.
12. Perillo NL, Pace KE, Seilhamer JJ, et al: Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739, 1995.
13. Rubinstein N, Alvarez M, Zwimer NW, et al: Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor immune privilege. Cancer Cell 5: 241-251, 2004.
14. Garín MI, Chu CC, Golshayan D, et al: Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109: 2058-2065, 2007.
15. Stillman BN, Hsu DK, Pang M, et al: Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176: 778-789, 2006.
16. Rabinovich GA, Daly G, Dreja H, et al: Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190: 385-398, 1999.
17. Bi S, Earl LA, Jacobs L, et al: Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J Biol Chem 283: 12248-12258, 2008.
18. Van der Leij J, van den Berg A, Harms G, et al: Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol Immunol 44: 506-513, 2007.
19. Stowell SR, Qian Y, Karmakar S, et al: Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180: 3091-3102, 2008.
20. Liu FT and Rabinovich GA: Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41, 2005.
21. Rabinovich GA: Galectin-1 as a potential cancer target. Br J Cancer 92: 1188-1192, 2005.
22. Van den Brule F, Califies S, Garnier F, et al: Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 83: 377-386, 2003.
23. Camby I, Belot N, Lefrance F, et al: Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61: 585-596, 2002.
24. He QY, Chen J, Kung HF, et al: Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271-278, 2004.
25. Chiang WF, Liu SY, Fang LY, et al: Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol 44: 325-334, 2008.
26. Blois SM, Ilarregui JM and Tometten M: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13: 1450-1457, 2007.